Goodwin advised Enfusion on the deal, while Davis Polk advised the representatives of the several underwriters. Enfusion, Inc. completed its initial public offering of 21,562,500 shares...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here